Association between Thyroid Cancer and Breast Cancer: Two Longitudinal Follow-Up Studies Using a National Health Screening Cohort
- PMID: 35207622
- PMCID: PMC8880453
- DOI: 10.3390/jpm12020133
Association between Thyroid Cancer and Breast Cancer: Two Longitudinal Follow-Up Studies Using a National Health Screening Cohort
Abstract
Background: The purpose of this study was to evaluate the association between thyroid cancer and breast cancer. Methods: Data from the Korean National Health Insurance Service-Health Screening Cohort were collected from 2002 to 2013. In study I, 3949 thyroid cancer participants were 1:4 matched with 15,796 control I participants, and hazard ratios (HRs) with 95% confidence intervals (CIs) for breast cancer were evaluated using a stratified Cox proportional hazard model. In study II, 3308 breast cancer participants were 1:4 matched with 13,232 control II participants, and HRs with 95% CIs for thyroid cancer were assessed in the same way as in study I. In the subgroup analyses, associations were analyzed according to radioactive iodine (RAI) treatment and age (<60 years old and ≥60 years old). Results: The adjusted HR for breast cancer in the thyroid cancer group was 1.64 (95% CI = 1.13-2.39, p = 0.010). The adjusted HR for thyroid cancer in the breast cancer group was 1.91 (95% CI = 1.47-2.49, p < 0.001). In the subgroup analyses, the groups that were older and not treated with RAI treatment showed consistent results in study I, and the younger and older groups showed consistent results in study II. Conclusions: Based on this cohort study, breast and thyroid cancer have a reciprocal positive association.
Keywords: breast cancer; longitudinal follow-up study; national health screening cohort; radioactive iodine treatment; thyroid cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer.J Clin Endocrinol Metab. 2015 Sep;100(9):3486-93. doi: 10.1210/JC.2014-2896. Epub 2015 Jul 6. J Clin Endocrinol Metab. 2015. PMID: 26147607
-
Mortality and cause of death in physical activity and insufficient physical activity participants: a longitudinal follow-up study using a national health screening cohort.BMC Public Health. 2020 Sep 29;20(1):1469. doi: 10.1186/s12889-020-09564-x. BMC Public Health. 2020. PMID: 32993602 Free PMC article.
-
Effects of radioactive iodine treatment on cardiovascular disease in thyroid cancer patients: a nationwide cohort study.Ann Transl Med. 2020 Oct;8(19):1235. doi: 10.21037/atm-20-5222. Ann Transl Med. 2020. PMID: 33178767 Free PMC article.
-
Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Systematic Review and Meta-analysis.JAMA Netw Open. 2021 Sep 1;4(9):e2125072. doi: 10.1001/jamanetworkopen.2021.25072. JAMA Netw Open. 2021. PMID: 34533571 Free PMC article.
-
Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey.Front Endocrinol (Lausanne). 2020 Jul 10;11:381. doi: 10.3389/fendo.2020.00381. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32754115 Free PMC article. Review.
Cited by
-
Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.Cancers (Basel). 2022 Oct 19;14(20):5117. doi: 10.3390/cancers14205117. Cancers (Basel). 2022. PMID: 36291901 Free PMC article. Review.
-
Thyroidal and Extrathyroidal Requirements for Iodine and Selenium: A Combined Evolutionary and (Patho)Physiological Approach.Nutrients. 2022 Sep 20;14(19):3886. doi: 10.3390/nu14193886. Nutrients. 2022. PMID: 36235539 Free PMC article. Review.
-
Assessing the causality between thyroid and breast neoplasms: A bidirectional Mendelian randomization study.Front Oncol. 2022 Dec 5;12:973161. doi: 10.3389/fonc.2022.973161. eCollection 2022. Front Oncol. 2022. PMID: 36544708 Free PMC article.
-
Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database.Endocrinol Metab (Seoul). 2023 Feb;38(1):10-24. doi: 10.3803/EnM.2023.102. Epub 2023 Feb 9. Endocrinol Metab (Seoul). 2023. PMID: 36758542 Free PMC article. Review.
References
-
- Cancer Statistics. [(accessed on 21 January 2020)]. Available online: https://ncc.re.kr/main.ncc?uri=english/sub04_Statistics.
-
- Howlader N., Noone A., Krapcho M., Miller D., Bishop K., Altekruse S., Kosary C., Yu M., Ruhl J., Tatalovich Z. SEER Cancer Statistics Review, 1975–2013. Volume 19 National Cancer Institute; Bethesda, MD, USA: 2016.
Grants and funding
LinkOut - more resources
Full Text Sources